Live

China, EU retaliate as Trump's massive tariffs kick in across the world. See the latest.

LSE - Delayed Quote CHF

Ypsomed Holding AG (0QLQ.L)

311.00

-16.00

(-4.89%)

At close: 4:31:22 PM GMT+1

“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Medical Device Network 4 months ago

NVO

YPSN.SW
Ypsomed and BD to enhance high-viscosity drug delivery

The collaboration will integrate BD's Neopak XtraFlow glass prefillable syringe with Ypsomed’s YpsoMate 2.25 autoinjector platform.

Medical Device Network 5 months ago

YPSN.SW
Astria Therapeutics taps Ypsomed’s autoinjector for hereditary angioedema drug delivery

Astria Therapeutics plans to deploy hereditary angioedema (HAE) candidate STAR-0215 using Ypsomed’s Ypsomate autoinjector.

Pharmaceutical Technology 7 months ago

YPSN.SW

GLDAF
MTD closes acquisition of Ypsomed’s BGM business

The acquisition brings technologies such as the G34 pen needle, and a range of pen needles to MTD’s production network.

Medical Device Network 7 months ago

YPSN.SW

Performance Overview

Return	0QLQ.L	MSCI WORLD (^990100-USD-STRD)
YTD	-5.04%	-12.88%
1-Year	-16.22%	-5.34%
3-Year	+96.35%	+7.23%